Incorporating genetic data to clinical information and therapies:
NGS / SNPChip: Comprehensive technological solutions for precise, personalized medicine & biology
GGenetracer Biotech has the authorization of the counseling of health as authorized Center of Genetics (U.78) to market its first two major lines of business, products based on genotyping (SNPchip) and sequencing (NGS).
Our goal is to both scientific development and the marketing of multiple products in the field of nutritional Genomics, pharmacogenetics, cancer, (lung cancer and colon, breast cancer or the full panel of cancer), hereditary diseases, the exome and transcriptome analysis.
These products can be self-developed based on a close collaboration with health workers through which it will be available or full (laboratories of clinical analyses, hospitals, offices, pharmacy, etc).
“I had an excellent experience working with Genetracer Biotech on Ampliseq Transcriptome Human Gene Panel with RNA samples from urine, formalin fixed paraffin embedded and laser capture microdissection.”
Genetracer Biotech continues exploring various international markets through the “Programa de Asesores Comerciales en Destino” organized by ICEX Next. In this context, Genetracer biotech hosted the visit from the commercial [...]
Between 12 and 15 October and based on experience gained in the field of oncology, Genetracer Biotech has participated as EQA (External Quality Assessment) Assessor Scheme for lung cancer. The objective is [...]
After the good experience with our previous contact with the “Programa de Asesores Comerciales en Destino” promoted by the ICEX-Next, Genetracer Biotech pursues contacts with different Commercial Advisors. Early October, [...]